Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A ROTH

Showing results (501-510 of 508) with videos related to

Pageof 51
Sort By:
You have reached the last page of results.This site can display upto 508 results.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 18, 2019
Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experienceK G Mitchell, D B Nelson, E M Corsini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancerJ A Ajani, L Xiao, J A Roth, et al.
Journal of the National Cancer Institute|April 20, 2001
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancerS M Lippman, J J Lee, D D Karp, et al.
Seminars in Oncology|August 15, 1998
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacementJ A Roth, S G Swisher, J A Merritt, et al.
Nature Medicine|September 1, 1996
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancerJ A Roth, D Nguyen, D D Lawrence, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50J F Gainor, H Rizvi, E Jimenez Aguilar, et al.
Cancer Gene Therapy|May 16, 2000
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)N Yen, C G Ioannides, K Xu, et al.
Journal of the National Cancer Institute|May 18, 1999
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancerS G Swisher, J A Roth, J Nemunaitis, et al.
Pageof 51

Showing results (501-510 of 508) with videos related to

Sort By:
Pageof 51
You have reached the last page of results.This site can display upto 508 results.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 18, 2019
Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experienceK G Mitchell, D B Nelson, E M Corsini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancerJ A Ajani, L Xiao, J A Roth, et al.
Journal of the National Cancer Institute|April 20, 2001
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancerS M Lippman, J J Lee, D D Karp, et al.
Seminars in Oncology|August 15, 1998
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacementJ A Roth, S G Swisher, J A Merritt, et al.
Nature Medicine|September 1, 1996
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancerJ A Roth, D Nguyen, D D Lawrence, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50J F Gainor, H Rizvi, E Jimenez Aguilar, et al.
Cancer Gene Therapy|May 16, 2000
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)N Yen, C G Ioannides, K Xu, et al.
Journal of the National Cancer Institute|May 18, 1999
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancerS G Swisher, J A Roth, J Nemunaitis, et al.
Pageof 51